Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongfeng Kangning Tablets in Acute Gouty Arthritis (Phase II, dose-finding)
CTR20230298Phase 2Active
- Sponsor
- Tianjin Tianzhong Pharmaceutical Technology
- Start
- Feb 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Tongfeng Kangning Tablets in acute gout flare, sponsored by Tianjin Tianzhong Pharmaceutical Technology. Started Feb 2023; status: active.
02
Drugs
Tongfeng Kangning Tablets
03
Conditions
acute gout flare
Beyond the preview
Go deeper on CTR20230298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230298.